Trump had earlier said on March 24 that he will announce tariffs on automobiles, pharmaceuticals and aluminum in the near ...

The Trust has purchased the apartment on the 61st floor of Tower A, which is 17,384 sq ft big, according to documents ...

On Tuesday, Zydus Life shares closed at Rs 903.1, up 1.1% on the BSE, while the benchmark Sensex surged 1.53%. The stock has ...

The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...

Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 ...

Zydus Family Trust purchased a luxury apartment in Mumbai's Oberoi Realty project for ₹200 crore. Covering 17,384 sq ft, the ...

The company got the nod to manufacture and market apalutamide tablets, 60 mg, the generic equivalent of Erleada tablets, 60 ...

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...

Eluxadoline tablets will be produced at Zydus Lifesciences Ltd (SEZ) in Ahmedabad, the company said in an exchange filing.

As per the IQVIA MAT January 2025 data, apalutamide tablets registered annual sales of $1099.80 million in the United States markets.

Inspection occurred from March 10, 2025 to March 14, 2025 and ended with no observations with full compliance.

Zydus Life shares performance On Tuesday, Zydus Life shares closed at Rs 903.1, up 1.1% on the BSE, while the benchmark ...